Cyber framework
FDA 524B
§524B + SPDF.
NMPA
NMPA Cybersecurity Guidance + MLPS 2.0 + PIPL + DSL.
Takeaway
China stacks four regimes on top of the device rules.
Head to head
United States and China medical-device cybersecurity, compared.
Bottom line
NMPA is the largest reformat on the crosswalk. FDA evidence stays useful, but China overlays MLPS 2.0 (cybersecurity classification), PIPL (personal information), DSL (data security), and data-localisation expectations that have no FDA analogue. Plan on ~45% reuse and a 9-12 month timeline.
Who this is for · US sponsors evaluating the China market and how much extra work it costs.
Cyber framework
FDA 524B
§524B + SPDF.
NMPA
NMPA Cybersecurity Guidance + MLPS 2.0 + PIPL + DSL.
Takeaway
China stacks four regimes on top of the device rules.
SBOM
FDA 524B
Mandatory.
NMPA
Expected for connected devices; format not yet standardised.
Takeaway
CycloneDX still works, but expect Chinese translation of component descriptions.
Data residency
FDA 524B
No federal localisation rule.
NMPA
Personal & important data must be stored on Chinese servers.
Takeaway
Architecture decisions made for the US may force a re-deploy in China.
Full profile
FDA Premarket Cybersecurity Guidance & FD&C §524B
Open profileFull profile
Technical Review Guideline on Medical Device Cybersecurity (2022 rev.)
Open profileGenerally no — PIPL and DSL push personal and 'important' data into Chinese-hosted environments, with CAC security assessment for cross-border transfers above defined thresholds.